Arxx Therapeutics AS
Latest round
- Seed
Last raised
- May 2021
Total raised
- $13M
Investors
- 10
About Arxx Therapeutics AS
Based in Oslo, Norway, and founded in 2018 by co-founders Jorg Klingelhofer and Jonas Hallen, Arxx Therapeutics AS operates as a biopharmaceutical-based company providing medicine, drug development and molecular biology for patients suffering from fibrotic disease.V. merged with Arxx Therapeutics AS, a portfolio company of Rasmussen Gruppen AS, Investinor, altitude Capital Management, Veen Eiendom AS, P53, Sarsia Management, Trond Mohn Stiftelsen, MP Pensjon, Asteroid Bakken AS and Andenes Investments, to form Calluna Pharma. Arxx Therapeutics AS developed therapeutic strategies for Systemic sclerosis, which is an autoimmune disease that causes fibrosis and tissue dysfunction in human body organs. The company offers S100A4, that boosts the body and targets lesional tissue systemically in patients with SSc disease activity, skin fibrosis and pulmonary function. It created AX-202, which supports patients that ameliorate fibrosis in both inflammatory and non-inflammatory models of skin fibrosis.
Who invested in Arxx Therapeutics AS
10 investors across 1 round
See all investors in Arxx Therapeutics AS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 4, 2021
Amount
$13M
Investors
Questions about Arxx Therapeutics AS
Who invested in Arxx Therapeutics AS?
Arxx Therapeutics AS has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arxx Therapeutics AS raised?
Arxx Therapeutics AS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arxx Therapeutics AS last raise money?
Arxx Therapeutics AS's most recent round on record is a Seed, in May 2021.
What does Arxx Therapeutics AS do?
Based in Oslo, Norway, and founded in 2018 by co-founders Jorg Klingelhofer and Jonas Hallen, Arxx Therapeutics AS operates as a biopharmaceutical-based company providing medicine, drug development and molecular biology for patients suffering from fibrotic disease.
Where is Arxx Therapeutics AS headquartered?
Arxx Therapeutics AS is headquartered in Oslo, Norway.
Which VCs invest in companies like Arxx Therapeutics AS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Arxx Therapeutics AS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Arxx Therapeutics AS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.